cDNA Cloning and Characterization of an Atrophin-1 (DRPLA Disease Gene)-Related Protein
Dentatorubral and pallidoluylsian atrophy (DRPLA) is a progressive neurological disorder characterized by neuronal degeneration, especially in the cerebellar dentate nucleus. DRPLA is caused by an unstable expansion of a CAG trinucleotide repeat coding for glutamine in a gene of unknown function, te...
Main Authors: | , , , , , |
---|---|
Format: | Article |
Language: | English |
Published: |
Elsevier
1996-04-01
|
Series: | Neurobiology of Disease |
Online Access: | http://www.sciencedirect.com/science/article/pii/S0969996196900121 |
id |
doaj-00ee289eb5fa4d7cb5eb07bc5129bfcf |
---|---|
record_format |
Article |
collection |
DOAJ |
language |
English |
format |
Article |
sources |
DOAJ |
author |
Farhat A. Khan Russell L. Margolis Scott L. Loev Alan H. Sharp Shi-Hua Li Christopher A. Ross |
spellingShingle |
Farhat A. Khan Russell L. Margolis Scott L. Loev Alan H. Sharp Shi-Hua Li Christopher A. Ross cDNA Cloning and Characterization of an Atrophin-1 (DRPLA Disease Gene)-Related Protein Neurobiology of Disease |
author_facet |
Farhat A. Khan Russell L. Margolis Scott L. Loev Alan H. Sharp Shi-Hua Li Christopher A. Ross |
author_sort |
Farhat A. Khan |
title |
cDNA Cloning and Characterization of an Atrophin-1 (DRPLA Disease Gene)-Related Protein |
title_short |
cDNA Cloning and Characterization of an Atrophin-1 (DRPLA Disease Gene)-Related Protein |
title_full |
cDNA Cloning and Characterization of an Atrophin-1 (DRPLA Disease Gene)-Related Protein |
title_fullStr |
cDNA Cloning and Characterization of an Atrophin-1 (DRPLA Disease Gene)-Related Protein |
title_full_unstemmed |
cDNA Cloning and Characterization of an Atrophin-1 (DRPLA Disease Gene)-Related Protein |
title_sort |
cdna cloning and characterization of an atrophin-1 (drpla disease gene)-related protein |
publisher |
Elsevier |
series |
Neurobiology of Disease |
issn |
1095-953X |
publishDate |
1996-04-01 |
description |
Dentatorubral and pallidoluylsian atrophy (DRPLA) is a progressive neurological disorder characterized by neuronal degeneration, especially in the cerebellar dentate nucleus. DRPLA is caused by an unstable expansion of a CAG trinucleotide repeat coding for glutamine in a gene of unknown function, termed atrophin-1, located on chromosome 12. To gain additional understanding of atrophin-1, we have isolated a second member of the atrophin-1 gene family by screening rat cDNA libraries. The 1006-amino-acid product of this gene, which we have termed rat atrophin related protein(rARP), does not contain a glutamine repeat, but it does contain two regions of alternating acidic and basic amino residues similar to those found in atrophin-1. rARP is widely expressed as both a 7.4- and a 9.4-kb message, with enrichment in cerebellum and testis. Like atrophin-1, the rARPin vitrotranslation product migrates more slowly on SDS–polyacrylamide gel electrophoresis than predicted by molecular weight. We conclude that, at least in the rat, polyglutamine is not an essential feature of the atrophin family of genes. |
url |
http://www.sciencedirect.com/science/article/pii/S0969996196900121 |
work_keys_str_mv |
AT farhatakhan cdnacloningandcharacterizationofanatrophin1drpladiseasegenerelatedprotein AT russelllmargolis cdnacloningandcharacterizationofanatrophin1drpladiseasegenerelatedprotein AT scottlloev cdnacloningandcharacterizationofanatrophin1drpladiseasegenerelatedprotein AT alanhsharp cdnacloningandcharacterizationofanatrophin1drpladiseasegenerelatedprotein AT shihuali cdnacloningandcharacterizationofanatrophin1drpladiseasegenerelatedprotein AT christopheraross cdnacloningandcharacterizationofanatrophin1drpladiseasegenerelatedprotein |
_version_ |
1724211391396577280 |
spelling |
doaj-00ee289eb5fa4d7cb5eb07bc5129bfcf2021-03-20T05:00:11ZengElsevierNeurobiology of Disease1095-953X1996-04-0132121128cDNA Cloning and Characterization of an Atrophin-1 (DRPLA Disease Gene)-Related ProteinFarhat A. Khan0Russell L. Margolis1Scott L. Loev2Alan H. Sharp3Shi-Hua Li4Christopher A. Ross5Laboratory of Molecular Neurobiology, Department of Psychiatry, Johns Hopkins University School of Medicine, Baltimore, Maryland, 21205-2196; Laboratory of Molecular Neurobiology, Department of Neuroscience, Johns Hopkins University School of Medicine, Baltimore, Maryland, 21205-2196; Laboratory of Molecular Neurobiology, Program in Cellular and Molecular Medicine, Johns Hopkins University School of Medicine, Baltimore, Maryland, 21205-2196Laboratory of Molecular Neurobiology, Department of Psychiatry, Johns Hopkins University School of Medicine, Baltimore, Maryland, 21205-2196; Laboratory of Molecular Neurobiology, Department of Neuroscience, Johns Hopkins University School of Medicine, Baltimore, Maryland, 21205-2196; Laboratory of Molecular Neurobiology, Program in Cellular and Molecular Medicine, Johns Hopkins University School of Medicine, Baltimore, Maryland, 21205-2196Laboratory of Molecular Neurobiology, Department of Psychiatry, Johns Hopkins University School of Medicine, Baltimore, Maryland, 21205-2196; Laboratory of Molecular Neurobiology, Department of Neuroscience, Johns Hopkins University School of Medicine, Baltimore, Maryland, 21205-2196; Laboratory of Molecular Neurobiology, Program in Cellular and Molecular Medicine, Johns Hopkins University School of Medicine, Baltimore, Maryland, 21205-2196Laboratory of Molecular Neurobiology, Department of Psychiatry, Johns Hopkins University School of Medicine, Baltimore, Maryland, 21205-2196; Laboratory of Molecular Neurobiology, Department of Neuroscience, Johns Hopkins University School of Medicine, Baltimore, Maryland, 21205-2196; Laboratory of Molecular Neurobiology, Program in Cellular and Molecular Medicine, Johns Hopkins University School of Medicine, Baltimore, Maryland, 21205-2196Laboratory of Molecular Neurobiology, Department of Psychiatry, Johns Hopkins University School of Medicine, Baltimore, Maryland, 21205-2196; Laboratory of Molecular Neurobiology, Department of Neuroscience, Johns Hopkins University School of Medicine, Baltimore, Maryland, 21205-2196; Laboratory of Molecular Neurobiology, Program in Cellular and Molecular Medicine, Johns Hopkins University School of Medicine, Baltimore, Maryland, 21205-2196Laboratory of Molecular Neurobiology, Department of Psychiatry, Johns Hopkins University School of Medicine, Baltimore, Maryland, 21205-2196; Laboratory of Molecular Neurobiology, Department of Neuroscience, Johns Hopkins University School of Medicine, Baltimore, Maryland, 21205-2196; Laboratory of Molecular Neurobiology, Program in Cellular and Molecular Medicine, Johns Hopkins University School of Medicine, Baltimore, Maryland, 21205-2196Dentatorubral and pallidoluylsian atrophy (DRPLA) is a progressive neurological disorder characterized by neuronal degeneration, especially in the cerebellar dentate nucleus. DRPLA is caused by an unstable expansion of a CAG trinucleotide repeat coding for glutamine in a gene of unknown function, termed atrophin-1, located on chromosome 12. To gain additional understanding of atrophin-1, we have isolated a second member of the atrophin-1 gene family by screening rat cDNA libraries. The 1006-amino-acid product of this gene, which we have termed rat atrophin related protein(rARP), does not contain a glutamine repeat, but it does contain two regions of alternating acidic and basic amino residues similar to those found in atrophin-1. rARP is widely expressed as both a 7.4- and a 9.4-kb message, with enrichment in cerebellum and testis. Like atrophin-1, the rARPin vitrotranslation product migrates more slowly on SDS–polyacrylamide gel electrophoresis than predicted by molecular weight. We conclude that, at least in the rat, polyglutamine is not an essential feature of the atrophin family of genes.http://www.sciencedirect.com/science/article/pii/S0969996196900121 |